Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 4 July 1997: Vol. 277. no. 5322, pp. 32 - 33 DOI: 10.1126/science.277.5322.32
|
|
News
AIDS THERAPIES:
The Daunting Challenge of Keeping HIV Suppressed
Jon Cohen
ST. PETERSBURG, FLORIDAWhen the media last year trumpeted the great advances being made against HIV, speculating about cures and even the end of AIDS, the researchers' own caveats tended to get drowned out. But at a meeting held here last week, emerging data about treatment failures sounded a discordant note that was hard to miss: While powerful new drug combinations are delaying disease and death, they have serious limitationsand clinicians and patients who ignore these shortcomings do so at their peril.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- The cellular HIV-1 Rev cofactor hRIP is required for viral replication.
- Z. Yu, N. Sanchez-Velar, I. E. Catrina, E. L. W. Kittler, E. B. Udofia, and M. L. Zapp (2005)
PNAS
102, 4027-4032
| Abstract »
| Full Text »
| PDF »
- Molecular and genetic characterization of a serotype A MATaCryptococcus neoformans isolate.
- S. M. Keller, M. A. Viviani, M. C. Esposto, M. Cogliati, and B. L. Wickes (2003)
Microbiology
149, 131-142
| Abstract »
| Full Text »
| PDF »
- Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro.
- J. Ma, S. Kennedy-Stoskopf, J. M. Jaynes, L. M. Thurmond, and W. A. Tompkins (2002)
J. Virol.
76, 9952-9961
| Abstract »
| Full Text »
| PDF »
- Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2',3'-Dideoxy-3'-Thiacytidine.
- E. K. Halvas, E. S. Svarovskaia, E. O. Freed, and V. K. Pathak (2000)
J. Virol.
74, 6669-6674
| Abstract »
| Full Text »
| PDF »
- Development of an In Vivo Assay To Identify Structural Determinants in Murine Leukemia Virus Reverse Transcriptase Important for Fidelity.
- E. K. Halvas, E. S. Svarovskaia, and V. K. Pathak (2000)
J. Virol.
74, 312-319
| Abstract »
| Full Text »
| PDF »
- Hypervariable region 3 residues of HIV type 1 gp120 involved in coreceptor utilization: Therapeutic and prophylactic implications.
- W.-K. Wang, T. Dudek, M. Essex, and T.-H. Lee (1999)
PNAS
96, 4558-4562
| Abstract »
| Full Text »
| PDF »
- Selective Inhibition of HIV-1 Reverse Transcriptase by an Antiviral Inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
- Z. Suo and K. A. Johnson (1998)
J. Biol. Chem.
273, 27250-27258
| Abstract »
| Full Text »
| PDF »
- Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Bistriazoloacridone Analog That Selectively Inhibits HIV-1 Transcription.
- J. A. Turpin, R. W. Buckheit Jr., D. Derse, M. Hollingshead, K. Williamson, C. Palamone, M. C. Osterling, S. A. Hill, L. Graham, C. A. Schaeffer, et al. (1998)
Antimicrob. Agents Chemother.
42, 487-494
| Abstract »
| Full Text »
| PDF »
|
|